Combined taVNS and tDCS in Subacute Stroke Patients

Disability Severity Assessment Using the Modified Rankin Scale (mRS),Motor Function Assessment Using Fugl-Meyer Assessment (FMA) for Upper Extremity (UE) and Lower Extremity (LE),Upper Limb Motor Function Evaluation Using the Wolf Motor Function Test (WMFT),Mobility and Balance Assessment Using the Time Up and Go Test (TUG)

Ischemic stroke, the most prevalent neurological disorder, is treated with medication and
 thrombectomy but with limited success, especially in chronic stages where traditional
 rehabilitation is the primary option. Stroke often leads to post-stroke autonomic imbalance,
 deteriorating functional outcomes and increasing recurrence risk. Emerging
 non-pharmacological treatments like Transcutaneous Auricular Vagus Nerve Stimulation (VNS)
 and Focused Transcranial Direct Current Stimulation (tDCS) offer new possibilities. VNS
 targets post-stroke tissue injury and promotes healing and neurogenesis, while tDCS aims to
 enhance motor learning by rebalancing brain activity. Both therapies seek to improve outcomes
 in both acute and chronic stroke stages.